[1]Petitclerc L, Sebastiani G, Gilbert G, et al. Liver fibrosis: Review of current imaging and MRI quantification techniques[J]. J Magn Reson Imaging, 2017, 45(5): 1276-1295.
[2]Zeng DW, Dong J, Liu YR, et al. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection[J]. World J Gastroenterol, 2016, 22(29): 6663-6672.
[3]Almpanis Z, Demonakou M, Tiniakos D. Evaluation of liver fibrosis: “Something old, something new…”[J]. Ann Gastroenterol, 2016, 29(4): 445-453.
[4]Barr RG, Ferraioli G, Palmeri ML, et al. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement[J]. Radiology, 2015, 276(3): 845-861.
[5]Tang A, Cloutier G, Szeverenyi NM, et al. Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques[J]. Am J Roentgenol, 2015, 205(1): 22-32.
[6]Chon YE, Choi EH, Song KJ, et al. Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis[J]. PLos One, 2012, 7(9): e44930.
[7]Friedrichrust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis[J]. Gastroenterology, 2008, 134(4): 960-974.
[8]Chung JH, Ahn HS, Kim SG, et al. The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis[J]. Clin Mol Hepatol, 2013, 19(2): 156-164.
[9]Mobarak L, Nabeel MM, Hassan E, et al. Real-time elastography as a noninvasive assessment of liver fibrosis in chronic hepatitis C Egyptian patients: a prospective study[J]. Ann Gastroenterol, 2016, 29(3): 358-362.
[10]Guo Y, Parthasarathy S, Goyal P, et al. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis[J]. Abdom Radiol, 2015, 40(4): 818-834.
[11]Pfeifer L, Adler W, Zopf S, et al. Acoustic radiation force impulse elastography: comparison and combination with other noninvasive tests for the diagnosis of compensated liver cirrhosis [J]. Eur J Gastroenterol Hepatol, 2017, 29(5): 524-530.
[12]Zhang D, Chen M, Wang R, et al. Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B[J]. Ultrasound Med Biol, 2015, 41(1): 7-14.
[13]Leung VY, Shen J, Wong VW, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation[J]. Radiology, 2013, 269(3): 910-918.
[14]Herrmann E, De Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by 2D-shear wave elastography: An individual patient data based meta-analysis[J]. Hepatology, 2017. [Epub ahead of print].
[15]Shi Y, Guo Q, Xia F, et al. MR Elastography for the Assessment of Hepatic Fibrosis in Patients with Chronic Hepatitis B Infection: Does Histologic Necroinflammation Influence the Measurement of Hepatic Stiffness?[J]. Radiology, 2014, 273(1): 88-98.
[16]Guo Y, Parthasarathy S, Goyal P, et al. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis[J]. Abdom Radiol, 2015, 40(4): 818-834.
[17]Shi Y, Xia F, Li QJ, et al. Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study[J]. Am J Gastroenterol, 2016, 111(6): 823-833.
[18]Wang QB, Zhu H, Liu HL, et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis[J]. Hepatology, 2012, 56(1): 239-247.
[19]Taouli B, Serfaty L. Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease[J]. Gastroenterology, 2016, 150(3): 553-556.
[20]解丽梅，郭启勇，刘鑫. 超声造影评价肝纤维化[J]. 中国医学影像技术，2009，25（8）：1447-1449.
[21]Abbattista T, Ridolfi F, Ciabattoni E, et al. Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography[J]. Radiol Med, 2008, 113(6): 860-874.
[22]Liu H, Liu J, Zhang Y, et al. Contrast-enhanced ultrasound and computerized tomography perfusion imaging of a liver fibrosis-early cirrhosis in dogs[J]. J Gastroenterol Hepatol, 2016, 31(9): 1604-1610.
[23]Ronot M, Asselah T, Paradis V, et al. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT[J]. Radiology, 2010, 256(1): 135-142.
[24]龙莉玲，黄仲奎，丁可，等. 多层螺旋CT肝脏灌注成像评价慢性肝纤维化、肝硬化的价值[J]. 中华放射学杂志，2012，46（4）：317-321.
[25]Sun H, Lu Z, Liang H, et al. Mesenteric and splenic contributions to portal venous CT perfusion in hepatic diffuse disease[J]. Int J Clin Exp Pathol, 2014, 7(11): 8082-8086.
[26]Aronhime S, Calcagno C, Jajamovich GH, et al. DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility[J]. Magn Reson Imaging, 2014, 40(1): 90-98.
[27]Ou HY, Bonekamp S, Bonekamp D, et al. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis[J]. Am J Roentgenol, 2013, 201(4): 596-602.
[28]王秋实，郭启勇，梁长虹，等. MR弥散加权成像在兔肝纤维化模型中的初步实验研究[J]. 中国医学影像技术，2007，23（7）：952-955.
[29]Annet L, Peeters F, Abarca-Quinones J, et al. Assessment of diffusion-weighted MR imaging in liver fibrosis[J]. J Magn Reson Imaging, 2007, 25(1): 122-128.
[30]Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience[J]. Am J Roentgenol, 2007, 189(4): 799-806.
[31]石喻，郭启勇，张兰，等. 3.0T MR弥散加权成像及张量成像评价肝纤维化的临床研究[J]. 中国医科大学学报，2012，41（4）：343-346.
[32]Ichikawa S, Motosugi U, Morisaka H, et al. MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography[J]. J Magn Reson Imaging, 2015, 42(1): 204-210.
[33]Dyvorne HA, Galea N, Nevers T, et al. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-a pilot study[J]. Radiology, 2013, 266(3): 920-929.
[34]张强，赵相轩，孙巍，等. 水通道蛋白在肝纤维化及肝硬化进程中的作用[J]. 临床肝胆病杂志，2016，32（6）：1192-1195.
[35]Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study[J]. Diabetes Metab Res Rev, 2010, 26(3): 200-205.
[36]Han TT, Guo QY, Xin J, et al. Quantitative assessment of early liver fibrosis in rats using 13N-NH3·H2O PET/CT[J]. Nucl Med Commun, 2016, 37(1): 92-98.
[37]李秋菊，李加慧，赵周社，等. DWI多b值水通道蛋白分子成像在肝纤维化早期诊断的价值[J]. 中国临床医学影像杂志，2014，25（10）：719-723.
[38]Lubner MG, Malecki K, Kloke J, et al. Texture analysis of the liver at MDCT for assessing hepatic fibrosis[J]. Abdom Radiol, 2017. [Epub ahead of print].
[39]Daginawala N, Li B, Buch K, et al. Using texture analyses of contrast enhanced CT to assess hepatic fibrosis[J]. Eur J Radiol, 2016, 85(3): 511-517.
[40]House MJ, Bangma SJ, Thomas M, et al. Texture-based classification of liver fibrosis using MRI[J]. J Magn Reson Imaging, 2015, 41(2): 322-328.
[41]Yu H, Buch K, Li B, et al. Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI[J]. J Magn Reson Imaging, 2015, 42(5): 1259-1265.
[42]Yokoo T, Wolfson T, Iwaisako K, et al. Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T[J]. Biomed Res Int, 2015, 2015: 387653.
[43]Zhang X, Xin J, Shi Y, et al. Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility study[J]. Nucl Med Biol, 2015, 42(3): 250-255.
[44]Farrar CT, Deperalta DK, Day H, et al. 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model[J]. J Hepatol, 2015, 63(3): 689-696.
[45]Chow AM, Tan M, Gao DS, et al. Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model[J]. Invest Radiol, 2013, 48(1): 46-54.
[46]Ahmad W, Ijaz B, Gull S, et al. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation[J]. Virol J, 2011, 8: 53.
[47]Caillot F, Hiron M, Goria O, et al. Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus-Infected Patients[J]. Am J Pathol, 2009, 175(1): 46-53.
[48]Okuaki T, Morita K, Namimoto T, et al. Assessment of the Hepatocyte Fraction for estimation of liver function[C]. Toronto: Proc 23rd Annual Meeting ISMRM, 2015.
[49]Motosugi U, Ichikawa T, Oguri M, et al. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index[J]. Magn Reson Imaging, 2011, 29(8): 1047-1052.
[50]Feier D, Balassy C, Bastati N, et al. Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging[J]. Radiology, 2013, 269(2): 460-468.
[51]Kumazawa K, Edamoto Y, Yanase M, et al. Liver analysis using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: Correlation with histological grading and quantitative liver evaluation prior to hepatectomy[J]. Hepatol Res, 2012, 42(11): 1081-1088.
[52]Goshima S, Kanematsu M, Watanabe H, et al. Gd-EOB-DTPA-enhanced MR imaging: Prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio[J]. J Magn Reson Imaging, 2012, 36(5): 1148-1153.
[53]Jiang J, Huang B, Bin G, et al. An experimental study on the assessment of rabbit hepatic fibrosis by using magnetic resonance T1ρ imaging[J]. Magn Reson Imaging, 2016, 34(3): 308-311.
[54]Noren B, Dahlqvist O, Lundberg P, et al. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy[J]. Eur J Radiol, 2008, 66(2): 313-320.
[55]Godfrey EM, Patterson AJ, Priest AN, et al. A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis[J]. Eur Radiol, 2012, 22(12): 2790-2797.
[56]Orlacchio A, Bolacchi F, Angelico M, et al. In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease[J]. Radiol Med, 2008, 113(2): 289-299.